Kezar Life Sciences, Inc. (KZR) Net Income (Loss) Attributable to Parent USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kezar Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2024.
  • Kezar Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$21.7 M, a 2.44% increase year-over-year.
  • Kezar Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$101 M, a 36.2% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$102 M, a 49.3% decline from 2022.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$68.2 M, a 24.9% decline from 2021.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$54.6 M, a 30.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$101 M -$21.7 M +$541 K +2.44% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$102 M -$32.3 M -$14.1 M -77.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$87.8 M -$23.1 M -$5.26 M -29.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$82.5 M -$24.3 M -$8.12 M -50.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$74.4 M -$22.2 M -$6.18 M -38.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$68.2 M -$18.2 M -$3.97 M -27.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$64.3 M -$17.8 M -$3.39 M -23.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$60.9 M -$16.2 M -$3.23 M -24.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$57.7 M -$16 M -$3.03 M -23.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$54.6 M -$14.2 M -$3.27 M -29.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$51.4 M -$14.5 M -$3.17 M -28.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$48.2 M -$13 M -$3.46 M -36.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$44.7 M -$13 M -$2.98 M -29.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$41.7 M -$10.9 M -$1.36 M -14.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$40.4 M -$11.3 M -$2.14 M -23.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$38.2 M -$9.5 M -$782 K -8.97% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$37.5 M -$10 M -$2.37 M -31% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$35.1 M -$9.58 M -$3.8 M -65.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$31.3 M -$9.15 M -$3.49 M -61.5% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$27.8 M -$8.72 M -$1.94 M -28.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$25.9 M -$7.64 M -$2.7 M -54.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$23.2 M -$5.78 M -$3.48 M -151% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$19.7 M -$5.66 M -$3.58 M -172% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$16.1 M -$6.78 M -$4.9 M -260% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$11.2 M -$4.95 M -$2.69 M -119% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$8.52 M -$2.3 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 -$2.08 M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-26
Q2 2017 -$1.88 M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-26
Q1 2017 -$2.26 M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.